› Endurance training is the mainstay in the exercise and sports therapy of cardiovascular patients. Both morbidity and mortality are improved in the long-term. › The importance of this therapy is still underestimated, and it seems prudent to give individualized training recommendations on mode, duration and intensity of physical activity, analogous to prescription of medication. The level of fitness being low in especially cardiovascular patients, the aim should be to start with a rather low intensity and duration ("begin low, go slow") with clear instructions for increasing the exertion. 
Plan the Training
Before prescribing a training plan for cardiac patients with normal or near-normal ejection fraction, an exercise test to the maximum attainable workload is necessary in order to determine the maximum heart rate achieved. This can be on a treadmill or bicycle on a graded basis according to the diagnostic guidelines (29) . Adequate testing achieves at least 85% (submaximal) or optimal 100% of the maximal heart rate (220 -age in years) (29) or the peak VO 2 (maximum oxygen uptake in cardiopulmonary exercise test CPET) achieving at least a RER (respiratory exchange rate) of 1.10 or higher (10, 26) . Alternative models include: heart rate 208-0.7 x age for females and 206-0.88 x age for males. Medication may require some adjustment, especially for betablockers (164-0.7 x age) (5) . The German Guideline for Physical Activity in Secondary Prevention (4) recommends 20-30 minutes 5 times a week, or 100-150 minutes at 60-75% of the maximum heart rate achieved in the stress test, respectively 40-60% of the heart rate reserve (maximum heart rate minus resting heart rate) The heart rate reserve method is considered preferable for patients with chronotropic incompetence, i.e. patients on betablockers. On the Borg scale (of percieved exertion, 6 no exertion, 19/20 very, very hard) that equates to 11 to 13. This is consistent with current international guidelines and reviews (27, 32) . These emphasize training in terms of volume (= intensity x duration). 150 minutes/week at 3.5-6 METs (metabolic equivalents, approximately 50-100 watts with 70 kg body weight), in the "moderate" range (500-1000 MET-min, approx. 550-1100kcal/week, optimal up to 1500kcal ). Alternatively, higher ("vigorous") activity levels can be set, i.e. 75 minutes/ week at 6-8.5 METs (about 100-150 watt), on the Borg scale 14 to 16. Low fitness levels are observed in the vast majority of patients with coronary artery disease (CAD). The SAINTEX-CAD study (6) in stable coronary patients without compromised ejection fraction reported that endurance training intensity of up to 80-85% of the maximum heart rate achieved was feasable and safe, if tolerated. Training zones from low to high intensity are summarized in table 1 (30, 31) . For details on different training modes see publication cited (13) . In Germany, a unique system exists whereby exercise can be prescribed in so-called "Rehabilitationssportgruppen" or Rehab exercise groups, which unfortunately are underused (15) .
In the growing subgroup of the "elderly" (75 years and older), training is absolutely necessary to maintain mobility and independence. With increasing age, the fitness category declines physiologically in the general population (reduced by around 30% from the age of 50 up to 70 and older) (16) . This group is at risk for overtraining, frailty and falling. The maxim: "Begin low, go slow" applies here. Training can start at 50% of maximum heart rate achieved and only 3 (-4) times a week for 10 (-15) minutes, with low increments every 2 weeks for example.
The same applies for women, who often have lower fitness levels (than same-aged men). Among patients with CAD, the female subgroup are generally older, have more comorbidities, and the course of disease and prognosis is more adverse than in the male subgroup. At the beginning of cardiac rehabilitation, women achieve a peak VO 2 of 14.5ml/kg/min, which is similar to that of patients with heart failure (1).
Heart Failure
In heart failure, calculating the risk is the first step in initiation of prescribed exercise . In addition to clinical assessment (low systolic blood pressure during exercise test and reduced heart rate recovery) and imaging techniques (low ejection fraction) CPET variables are important. Peak VO 2 lower than 14ml/kg/ min (12 with betablockers), first ventilatory threshold lower than 9ml/kg/min combined with VE/VCO 2 slope beyond 36 and exercise oscillatory ventilation is associated with higher risk (10, 11, 18) . If the patient presents with the above clinical conditions, optimizing therapy must first be urgently addressed before initiating training. In all others, CPET is the gold standard to determine the ventilatory thresholds (see Figure 1,  (3) ). This applies to heart failure with reduced ejection fraction (HFrEF) as well as to heart failure with preserved ejection fraction (HFpEF).
However, a paucity of evidence proving benefits of exercice training in HFpEF warrants caution. The optimal training range is at the first ventilatory threshold (usually at 40-60% of VO 2 max, (10, 11) ). Some data show that a better effect is achieved above this threshold without risk. Because of the "slow component" of the VO 2 kinetics, it should be well under the second ventilatory threshold (usually at 60-70% of VO 2 max). As a rule of thumb, it should be 10 watts less for a 10 watt/min incremental exercise test protocol (20) . But there is not much scientific evidence for this yet. The maximum heart rate for the training can be estimated in correlation to the ventilatory thresholds. If a maximal stress test is not feasable and/or training levels are initiated at a very low level, either the Borg scale or the 6-minute walking test may provide orientation.
Relationship among indices of exercise intensity and training zones. HR max =maximum heart rate; HRR=heart rate reserve; METs=metabolic equivalents, I MET=individual metabolic resting demand, when sitting quiet, about 3.5ml oxygen/kg/min or 1kcal (4.2kJ/kg/h) in the general population; RPE, Borg rating of perceived exertion (6-20 scale (6, 22) . The authors compared ET and HIIT in CAD patients with normal ejection fraction. Two groups, each of 100 patients, were randomized to either "moderate" ET (target 75-80% of the maximum heart rate, approx. 150 minutes/week) or aerobic interval training (HIIT according to Wisloff (34) at target 90-95% and approx. 120 minute week). The actual heart rate achieved was 88% with ET (which was higher than expected) and under 90% with HIIT (which was lower than expected). In consequence, the increase in peak VO 2 was the same in both groups. Even after one year of follow-up, there was no difference between groups. The same was found in patients with angina after 4 weeks of high intensity training compared to moderate ET (21) . Remarkable is the finding in the Leuven group that the energy consumption was higher with ET. This effect is considered beneficial in patients with hypertension and diabetes mellitus (Metabolic Syndrome). The small "time-saving" (30 minutes exercise-time/week) with HIIT is offset by increased complexity of monitoring heart rate.
ET and HIIT were compared in heart failure patients in the recently-published SMARTEX-HF study (9) . Baseline mean ejection fraction was less than 35%, and NYHA (New York Heart Association) stage II-III with a predominantly ischaemic etiology. The exercise protocol was analogous to the Saintex CAD study. A total of 261 patients were allocated to either "moderate" ET (target 60-70% of maximum heart rate, 38 minutes/session) or aerobic interval training (HIIT according to Wisloff (34) at target 90-95% and 47 minutes/session). The actual training level was higher than per-protocol for 80% of the ET patients whereas 51% of the HIIT patients were below the protocol target levels. The mean increase in peak VO 2 once again was the same between groups. Adverse events were more frequent in the HIIT group. Again, no superiority for HIIT. Recently, a study was published (28) , which shows that positive peripheral muscular effects only occur with HIIT. However, the following question was asked: "who is the beneficiary candidate and how many patients may really tolerate HIIT...?".
What else?
There is a longstanding controversy about "overdose" (2, 19, 33) and about athletes and competitors, especially with cardiomyopathies, channelopathies and after ICD/CRT. These persons need an individual approach by experienced specialists (for further information (7, 14, 17, 23, 24) ).
Online Decision Making
There is a new tool that offers digital, interactive decision support for exercise prescription. For now, there is a pilot version of the EXPERT tool (based on the Expert Flowchart, (12) ). This flowchart assists physicians and healthcare professionals in choosing and adopting the optimal exercise intervention in patients with various cardiovascular diseases and/or combination of risk factors. It is now available as a web-based software (pilot). Clinical experience must be gathered with this tool.
Conclusion
In summary, more experience should be gained using higher training levels in ET patients with no complaints (approximately 80% of the maximum heart rate, possibly +5% more). For the different conditions in cardiac patients see table 2 (20) . Welltrained patients may be given the option to change from moderate intensity (150 min/week at 3.5-6 MET) to more challenging ("vigorous") intensity by shortening the duration (75min/week at 6-8.5 MET). Considering the situation in the unfit general population and particularly in cardiac patients (with growing risk of metabolic syndrome), the attainment of a "moderate" training level appears challenging. ET is especially beneficial in this population for energy balance. From today's point of view, the (small) subgroup suitable for HIIT remains to be Ausdauertraining bei Herz-/Kreislauf-Patienten defined scientifically and ET remains the mainstay. Clinicians should keep in mind "that it is the least active individuals who stand to benefit the most from even the smallest increments in exercise and physical activity -some is better than none" (33) . Let´s get moving! Evidence-based prescribable aerobic exercise intensity in cardiac patient groups (YES=Y). Intensity domains for which no scientific evidence is available in a specific population (NO=N); CAD=coronary artery disease; PCI=percutaneous coronary intervention; ICD=implantable cardioverter defibrillator; AF=atrial fibrillation; CABG=coronary artery by-pass grafting; CHF=chronic heart failure; LVAD=left ventricular assist device; a =Heart rate and/or work rate must in any case be lower than those corresponding to the ischaemic threshold; b =Heart rate may not be usable due to highly variable chronotropic response; c =Heart rate may not be usable due to denervation-related blunted chronotropic response. (Copyright 2012 by the European Society of Cardiology. Reprinted by permission of SAGE Publications, Ltd. www.sagepub.co.uk. (20) Table 2 
